Healthcare Industry News: Gamma Knife
News Release - April 12, 2006
Elekta Chosen to Deliver Complete Oncology IT Solution to Top London HospitalsSTOCKHOLM, Sweden--(HSMN NewsFeed)--April 12, 2006--Elekta (STO:EKATA), world leader in advanced radiation therapy, comprehensive cancer management and non-invasive treatment of brain disorders, today announced an order from Guy's & St Thomas' NHS Foundation Trust, London, UK, covering a wide-ranging oncology management system from IMPAC Medical Systems, a part of the Elekta Group and a leading provider of information technology solutions for oncology care.
IMPAC's integrated software system helps improve overall treatment and practice management across the spectrum of cancer care by streamlining diagnostic and treatment information, charge capture and billing, and scheduling information into a patient chart that is instantly accessible from remote locations by hospital staff.
Guy's & St Thomas' NHS Foundation Trust is made up of two of London's oldest and most well known teaching hospitals. These hospitals have a long history, dating back almost 900 years, and have been at the forefront of patient care and medical progress since they were founded. Both hospitals have built on these traditions and continue to have a reputation for excellence and innovation. The Trust currently uses Elekta's linear accelerators to deliver radiation therapy.
Following a wide-ranging search for a new cancer information management system, Guy's and St Thomas' has chosen IMPAC Medical Systems to supply this system, which in time will cover all cancer services at the Trust.
Initially, the IMPAC system will be used to support radiotherapy, chemotherapy, hematology, palliative care and oncology data analysis. With 500 users at the start, the system is designed to expand to more than 2000 users in the future.
The Trust's integrated system will enable cancer patients to be admitted to different clinics at the Trust where staff will have instant access to patients' medical records. Staff will immediately be able to see patients' diagnostic, chemotherapy or radiotherapy treatment information, allowing nurses and doctors to best meet patients' needs and provide continuity of treatment without losing valuable time in finding the correct information.
"At Elekta, we are proud to be able to contribute to ongoing improvements in British cancer care", says Tomas Puusepp, President and CEO of Elekta. "It is of great value for a cancer care provider to have one central information system covering the entire treatment process. We are currently installing such systems in the UK, France and other countries and we are very happy to now include Guy's and St Thomas' Hospitals in this list", ends Tomas Puusepp.
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain surgery and Elekta Synergy® for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the world's largest supplier of oncology software.
Elekta's systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approx. 1800 employees, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
About IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc., a company in the Elekta Group, provides healthcare IT solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC's open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as best-of-breed systems for anatomic pathology, clinical laboratory, and cancer registry. With products that range from diagnosis and treatment through long-term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency, and quality patient care. For more information about IMPAC's products or services, please call 1-650-623-8800 or visit www.impac.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.